News from Zyme and the companies we work with.

Leading Life Science Organisations Collaborate for Second London Bio-Innovation Week
One Nucleus, SLAS, and ELRIG will connect their communities through cross-event networking and partnering opportunities during London Bio-Innovation Week, taking place 7th - 11th December, 2026 One Nucleus’ Genesis conference [...]
Undecimal Bio launches with $18 million oversubscribed Seed financing to address ‘liver trap’ in siRNA therapeutic delivery
A spin-out focused on AI-enabled decoding of the deliverome Proprietary synthetic biology platform identifies conjugates that target RNA medicines beyond the liver, with initial focus on renovascular disease Round co-led [...]
Mursla Bio Publishes Peer-Reviewed Validation of Tissue-Specific Extracellular Vesicle Platform for Liquid Biopsy
Study published in Journal of Extracellular Vesicles validates platform for new class of liquid biopsy: multiomic disease biology of living cells from a chosen tissue, starting with the liver Platform [...]
Google DeepMind’s Nature Study on Watermarking AI-Designed Proteins Validated with Carterra HT-SPR
New paper published in Nature shows watermarks can be embedded in AI-generated proteins without compromising function, confirmed with binding kinetics data from Carterra’s LSA-XT Salt Lake City, Utah, 12 October, [...]
Amphista Therapeutics announces first patient dosed in AMX-883 Phase 1 clinical trial for acute myeloid leukemia
AMX-883, Amphista’s first asset to enter the clinic, is a potent, selective, orally bioavailable DCAF16-mediated BRD9 degrader targeting acute myeloid leukemia (AML) The first-in-human ‘BRAMLIE’ (BR(D9) AML Interventional Evaluation) trial [...]
Carterra advances lab-in-the-loop drug discovery through new scientific collaboration
Bringing together scientific and technical expertise to advance development of hardware and software aimed at enabling a new wave of AI-driven, autonomous biologics discovery Salt Lake City, Utah, 07 October, [...]
Cambridge and London Life Sciences Showcase returns during JPM Healthcare Week 2027
o2h co-discovery to host second edition of the Cambridge x London Life Sciences Showcase, taking place on 13 January 2027 at 111 Minna Gallery, San Francisco Event is designed to [...]
Shift Bioscience publication increases confidence in AI virtual cells for novel target discovery
· Nature Biotechnology publication details improved calibration framework for deep learning-based genetic perturbation models · Peer-reviewed study will inform large-scale screen to identify inhibition targets with applications in rejuvenation and age-related [...]
CN Bio announces expert speaker line-up and scientific program for inaugural Organ-on-a-chip e-Symposium
Four sessions across two days focusing on key drug discovery and development application areas of organ-on-a-chip technologies Expert-led presentations and panel discussions featuring leaders across research, regulatory and industry, including [...]
Laverock Therapeutics announces in vivo programmes in oncology and genetic medicine
Laverock's programmable gene control platform unlocks in vivo therapeutics with enhanced efficacy and safety London, UK, 30 September 2026: Laverock Therapeutics (‘Laverock’), a biotechnology company developing disease-responsive advanced therapies through [...]
Cytotrait appoints Dr Ian Jepson as Non-Executive Director
Accomplished international R&D executive, previously Syngenta, specialising in biotech trait development and genome editing technologies Follows £3M seed round in 20261 to expand capabilities of the Company’s core MOSS platform [...]
Eppendorf introduces the new SpinPro® 8 R high-speed centrifuge
First new floor-standing centrifuge developed since the integration of himac into the Eppendorf Group SpinPro 8 R combines high-speed performance with up to 6 L capacity and a selection of [...]
